Art

J-GLOBAL ID：202002276652679626   Reference number：20A1312468

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01

HER2陽性早期乳癌患者のトラスツズマブ治療の転帰:JBCRGコホート試験01の拡張追跡調査

Author (20)： Yamashiro Hiroyasu (Department of Breast Surgery, Tenri Hospital, Tenri, Nara, Japan) ,  Iwata Hiroji (Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan) ,  Masuda Norikazu (Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan) ,  Yamamoto Naohito (Division of Breast Surgery, Chiba Cancer Center, Chiba, Japan) ,  Nishimura Reiki (Department of Breast Oncology, Kumamoto Shinto General Hospital, Kumamoto City, Kumamoto, Japan) ,  Ohtani Shoichiro (Division of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan) ,  Sato Nobuaki (Department of Breast Oncology, Niigata Cancer Center Hospital, Niigata, Japan) ,  Takahashi Masato (Department of Breast Surgery, NHO Hokkaido Cancer Center, Sapporo, Hokkaido, Japan) ,  Kamio Takako (Department of Breast, Endocrine and Pediatric Surgery, Tokyo Women’s Medical University, Tokyo, Japan) ,  Yamazaki Kosuke (Japanese Red Cross Hokkaido College of Nursing, KitamiKitami, Hokkaido, Japan) ,  Saito Tsuyoshi (Department of Breast Surgery, Japanese Red Cross Saitama Hospital, Saitama, Japan) ,  Kato Makoto (Kato Breast Surgery Clinic, Kusatsu, Shiga, Japan) ,  Lee Tecchuu (Department of Breast Surgery, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan) ,  Kuroi Katsumasa (Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan) ,  Takano Toshimi (Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan) ,  Yasuno Shinji (Department of EBM Research, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan) ,  Morita Satoshi (Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan) ,  Ohno Shinji (Breast Oncology Center, The Cancer Institute Hospital of JFCR, Tokyo, Japan) ,  Toi Masakazu (Breast Cancer Unit, Kyoto University Hospital, Kyoto, Japan) ,  the JBCRG-C01 Collaborative Group
Material： Breast Cancer
Volume： 27  Issue： 4  Page： 631-641  Publication year： Jul. 2020 
JST Material Number： L3971A  ISSN： 1340-6868  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： 10 years survival rate ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1312468&from=J-GLOBAL&jstjournalNo=L3971A") }}

Author keywords (5)： Breast cancer ,  HER2-positive breast cancer ,  Cohort study ,  Trastuzumab ,  Prediction model

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Terms in the title (9)： HER2 ,  早期乳癌 ,  患者 ,  トラスツズマブ ,  治療 ,  転帰 ,  コホート試験 ,  拡張 ,  追跡調査